Posted in | News | Tin | Mining Business

Research Report on Global Indium Tin Oxide Market

Research and Markets has announced the addition of the "Global Indium Tin Oxide (ITO) Market 2015-2019" report to their offering.

China is estimated to have about 62% of the total indium reserves. The country is followed by Canada, Japan, and South Korea. China imposes significant duties on exports of the product to ensure ample availability of the element for its domestic end-user industries. However, in recent years the increased production of indium and the piling up of inventories have led to revision of the export policy. In 2014, China relaxed regulations to allow the trading of indium on the global markets. This relaxation of the trade barriers will result in enhanced availability of indium and its derivatives such as ITO in the global markets.

The report, Global ITO Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from various industry experts. The report includes a comprehensive discussion on the market, an extensive coverage on various types of production techniques, applications, and demand-supply dynamics in various geographies. The report provides comments on both the existing market landscape and its growth prospects over the forecast period. The report further includes a discussion of the key vendors operating in this market.

Key Vendors

  • Densitron Technologies
  • Efun Technologies
  • Indium
  • Nitto Denko
  • Touch International
  • Umicore Thin Film Products

Other Prominent Vendors

  • Corning Precision Material
  • Evonik
  • Green SMTe Swiss
  • JX Nippon Mining & Metals
  • Mitsui Mining & Smelting
  • Tosoh
  • ULVAC Technologies

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.